NEW YORK (GenomeWeb News) – Soft sales during the third quarter has forced Molecular Devices to cut its financial guidance for the period by between 8 percent and 12 percent, the company said today.
 
Molecular Devices said it now expects revenue for the three months ended Sept. 30 to be between $44 million and $46 million. In July the company said it expected to generate between $48 million and $52 million in the period.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.